# Melinta Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/melinta-therapeutics

- Industry: Biotechnology
- Headquarters: Parsippany, US
- Website: www.melinta.com
- Total disclosed funding: $199M
- Latest round: Series B (Nov 29, 2012)
- Investors on record: 14

## About

Founded in 2000 and based in Connecticut, US, Melinta Therapeutics, Inc., formerly known as Rib-X Pharmaceuticals Inc., operates as a developer of novel small molecule antibiotics for the treatment of serious infections. The company also offers products that are also used for the treatment of serious hospital gram-negative infections.

## Funding rounds

- Series B, Nov 29, 2012, $19M — Warburg Pincus, ABS Ventures, Vatera Healthcare Partners, Vox Equity Partners
- Series E, Jan 11, 2011, $20M — Warburg Pincus
- Series D, Feb 11, 2009, $25M — EuclidSR Partners, Oxford Bioscience Partners, Warburg Pincus, ABS Ventures, SR One, Axiom Venture Partners, MedImmune Ventures, Vox Equity Partners
- Series C, Jun 8, 2006, $50M — Cardinal Partners, EuclidSR Partners, Oxford Bioscience Partners, Warburg Pincus, ABS Ventures, Radius Ventures, SR One, Axiom Venture Partners, MedImmune Ventures
- Series B, May 1, 2003, $64M — Cardinal Partners, EuclidSR Partners, Oxford Bioscience Partners, Warburg Pincus, Zero Stage Capital, SR One, Axiom Venture Partners, Connecticut Innovations
- Series A, Jan 22, 2002, $22M — Cardinal Partners, EuclidSR Partners, Oxford Bioscience Partners, Zero Stage Capital, ABS Ventures, Connecticut Innovations, Axiom

## Investors

- Cardinal Partners (https://capitalatlas.ai/funds/cardinal-partners) — Series A, Series B, Series C
- EuclidSR Partners (https://capitalatlas.ai/funds/euclidsr-partners) — Series A, Series B, Series C, Series D
- Oxford Bioscience Partners (https://capitalatlas.ai/funds/oxford-bioscience-partners) — Series A, Series B, Series C, Series D
- Zero Stage Capital (https://capitalatlas.ai/funds/zero-stage-capital) — Series A, Series B
- ABS Ventures (https://capitalatlas.ai/funds/abs-ventures) — Series A, Series C, Series D, Series B
- Connecticut Innovations (https://capitalatlas.ai/funds/connecticut-innovations) — Series A, Series B
- Axiom — Series A
- Warburg Pincus (https://capitalatlas.ai/funds/warburg-pincus) — Series B, Series C, Series D, Series E
- SR One (https://capitalatlas.ai/funds/sr-one) — Series B, Series C, Series D
- Axiom Venture Partners (https://capitalatlas.ai/funds/axiom-venture-partners) — Series B, Series C, Series D
- Radius Ventures (https://capitalatlas.ai/funds/radius-ventures) — Series C
- MedImmune Ventures (https://capitalatlas.ai/funds/medimmune-ventures) — Series C, Series D
- Vox Equity Partners (https://capitalatlas.ai/funds/vox-equity-partners) — Series D, Series B
- Vatera Healthcare Partners — Series B